References
Health Canada. BENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury Internet Document : 4 Apr 2019. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69506a-eng.php
Health Products Regulatory Authority. Benlysta (Belimumab) - Important Safety Information from GlaxoSmithKline Pharmaceuticals as approved by the HPRA Internet Document : 2 Apr 2019. Available from: URL: https://www.hpra.ie/homepage/medicines/safety-notices/item?t=/benlysta-(belimumab)---important-safety-information-from-glaxosmithkline-pharmaceuticals-as-approved-by-the-hpra&id=53d20b26-9782-6eee-9b55-ff00008c97d0
Rights and permissions
About this article
Cite this article
Belimumab: risk of depression, suicidal ideation. Reactions Weekly 1748, 2 (2019). https://doi.org/10.1007/s40278-019-59918-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-59918-0